Janumet Tablet is an oral prescription medication designed specifically for individuals managing Type 2 Diabetes. It combines two highly effective anti-diabetic agents—Sitagliptin and Metformin hydrochloride. Sitagliptin is a DPP-4 inhibitor, while Metformin is a biguanide. Together, they offer a powerful synergy to regulate blood sugar levels more effectively than either drug used alone. Approved by the FDA and available in many countries, Janumet has been adopted as a trusted treatment for those who require more than just Metformin or lifestyle adjustments to maintain healthy glucose levels. Its role in modern diabetes care is well-established, offering not only glycemic control but also the promise of better long-term outcomes.